Figure 6.

Antiviral effects of doxorubicin under co-treatment condition. The virus was treated with doxorubicin at different concentrations and the virus drug mixture was used for infection. Infected Vero CCL-81 cells were incubated for 120 h after infection. The culture filtrates were used for the FFU assay. Experiments were performed in triplicate at three independent time points. Results were plotted as mean log10 of focus-forming unit/mL ± standard error. All the treatment groups were compared with a virus control (VC) group (infected cells which did not receive drugs). **** p < 0.0001.